Literature DB >> 2403633

ras oncogene activation of a VL30 transcriptional element is linked to transformation.

R D Owen1, D M Bortner, M C Ostrowski.   

Abstract

The activity of a murine VL30 transcriptional element was increased 20-fold in transient assays by coexpression of mutant ras genes. The cis element did not respond to ras in a revertant cell line that was transformation defective. Therefore, ras-dependent alterations in transcription and ras transformation are linked. Deletion analysis of the VL30 long-terminal-repeat U3 region showed that a minimal 53-base-pair segment is required in cis for oncogene activation of transcription. Gel retention assays using a probe that contained the minimal cis element revealed that a unique complex was formed with nuclear proteins prepared from transformed cells. Exonuclease III footprinting and gel retention experiments that used oligonucleotide probes and competitors indicated that two distinct nuclear factors interact with the minimal cis-responsive element. Site-directed deletion of the 5'-proximal binding site (TGACTCT) resulted in a complete loss of ras responsiveness. However, deletion of this site did not affect stimulation by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA). These data are consistent with the hypothesis that ras and TPA signal transduction mechanisms for transcriptional activation are distinct.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403633      PMCID: PMC360706          DOI: 10.1128/mcb.10.1.1-9.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

1.  Rapid and selective alterations in the expression of cellular genes accompany conditional transcription of Ha-v-ras in NIH 3T3 cells.

Authors:  R D Owen; M C Ostrowski
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

2.  A gene activated by growth factors is related to the oncogene v-jun.

Authors:  K Ryder; L F Lau; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

3.  Prevalence of ras gene mutations in human colorectal cancers.

Authors:  J L Bos; E R Fearon; S R Hamilton; M Verlaan-de Vries; J H van Boom; A J van der Eb; B Vogelstein
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

Review 4.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Transformation by Rous sarcoma virus induces a novel gene with homology to a mitogenic platelet protein.

Authors:  S Sugano; M Y Stoeckle; H Hanafusa
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

6.  Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor.

Authors:  P Angel; M Imagawa; R Chiu; B Stein; R J Imbra; H J Rahmsdorf; C Jonat; P Herrlich; M Karin
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

7.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements.

Authors:  W Lee; P Mitchell; R Tjian
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

Review 8.  Fos-associated protein p39 is the product of the jun proto-oncogene.

Authors:  F J Rauscher; D R Cohen; T Curran; T J Bos; P K Vogt; D Bohmann; R Tjian; B R Franza
Journal:  Science       Date:  1988-05-20       Impact factor: 47.728

9.  Firefly luciferase gene: structure and expression in mammalian cells.

Authors:  J R de Wet; K V Wood; M DeLuca; D R Helinski; S Subramani
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

10.  A Harvey-ras responsive transcription element is also responsive to a tumour-promoter and to serum.

Authors:  J L Imler; C Schatz; C Wasylyk; B Chatton; B Wasylyk
Journal:  Nature       Date:  1988-03-17       Impact factor: 49.962

View more
  11 in total

1.  The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity.

Authors:  A Buijs; L van Rompaey; A C Molijn; J N Davis; A C Vertegaal; M D Potter; C Adams; S van Baal; E C Zwarthoff; M F Roussel; G C Grosveld
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Analysis of the v-myb structural components important for transactivation of gene expression.

Authors:  D M Bortner; M C Ostrowski
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

Review 3.  Large non-coding RNAs: missing links in cancer?

Authors:  Maite Huarte; John L Rinn
Journal:  Hum Mol Genet       Date:  2010-08-20       Impact factor: 6.150

4.  The transactivation potential of a c-Myc N-terminal region (residues 92-143) is regulated by growth factor/Ras signaling.

Authors:  M S Colman; M C Ostrowski
Journal:  Nucleic Acids Res       Date:  1996-05-15       Impact factor: 16.971

5.  Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent-kinase-independent mechanism.

Authors:  K Inoue; C J Sherr
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

6.  Transcriptional activation of a conserved sequence element by ras requires a nuclear factor distinct from c-fos or c-jun.

Authors:  R D Owen; M C Ostrowski
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

7.  Attenuation of glucocorticoid receptor levels by the H-ras oncogene.

Authors:  V R Martins; M M Brentani; P R Housley
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

8.  Roles of PSF protein and VL30 RNA in reversible gene regulation.

Authors:  Xu Song; Ying Sun; Alan Garen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-03       Impact factor: 11.205

9.  Regulation of proto-oncogene transcription, cell proliferation, and tumorigenesis in mice by PSF protein and a VL30 noncoding RNA.

Authors:  Gang Wang; Ying Cui; Guangfeng Zhang; Alan Garen; Xu Song
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-11       Impact factor: 11.205

10.  A somatic role for the histone methyltransferase Setdb1 in endogenous retrovirus silencing.

Authors:  Masaki Kato; Keiko Takemoto; Yoichi Shinkai
Journal:  Nat Commun       Date:  2018-04-27       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.